Loading…
Loading…
TIKRF (Tikcro Technologies Ltd.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for TIKRF and 80,000+ other tickers.
See exactly how TIKRF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TIKRF and 80,000+ other tickers.
Tikcro Technologies Ltd., an Israeli enterprise, is primarily involved in advancing biotechnology projects. Among its offerings is anti-cytotoxic T-lymphocyte-associated protein 4, which is utilized for immunotherapeutic approaches to cancer. The company, established in 1999, was previously known as Tioga Technologies Ltd. before rebranding to its current name in September 2003. Its main office is located in Hadera, Israel.
TEL AVIV, Israel, March 29, 2021 /PRNewswire/ -- Tikcro Technologies Ltd. (OTC: TIKRF) today announced that an Extraordinary General Meeting of Shareholders will be held on Thursday, April 29, 2021 at 9:30 a.m.
TEL AVIV, Israel, March 22, 2021 /PRNewswire/ -- Tikcro Technologies Ltd. (OTC: TIKRF) today announced that its Board of Directors has decided to take steps required to distribute the company's net cash to its shareholders.